1. Probiotic effects on immunity and microbiome in HIV-1 discordant patients
- Author
-
Carlos Blázquez-Bondia, Mariona Parera, Francesc Català-Moll, Maria Casadellà, Aleix Elizalde-Torrent, Meritxell Aguiló, Jordi Espadaler-Mazo, José Ramon Santos, Roger Paredes, and Marc Noguera-Julian
- Subjects
probiotics ,prebiotics ,synbiotics ,HIV ,immune reconstitution ,Immunologic diseases. Allergy ,RC581-607 - Abstract
BackgroundSome HIV-1 infected patients are unable to completely recover normal CD4+ T-cell (CD4+) counts after achieving HIV-1 suppression with combined Antiretroviral Therapy (cART), hence being classified as immuno-discordant. The human microbiome plays a crucial role in maintaining immune homeostasis and is a potential target towards immune reconstitution.SettingRECOVER (NCT03542786) was a double-blind placebo-controlled clinical trial designed to evaluate if the novel probiotic i3.1 (AB-Biotics, Sant Cugat del Vallès, Spain) was able to improve immune reconstitution in HIV-1 infected immuno-discordant patients with stable cART and CD4+ counts
- Published
- 2022
- Full Text
- View/download PDF